Ultraproct (suppositories): Supply issue

Supply issue Active

Because of delays at the factory where Ultraproct is made, the suppository presentation is out of stock.

10 November 2026 | Stock available again

Stock of Ultraproct is available from the supplier again. It can take another 2 or 3 weeks to reach pharmacies around the country.

Ultraproct suppositories were out of stock

Because of delays at the factory where Ultraproct is made, the suppositories were out of stock during 2026. 

The ointment remained available. 

The active ingredients in Ultraproct are fluocortolone caproate with fluocortolone pivalate and cinchocaine.

Schedule listing for Ultraproct(external link)

Alternatives 

Ultraproct ointment is available. 

We listed Scheriproct, as an alternative because Proctosedyl was also out of stock. Sheriproct is not Medsafe approved. It was listed as an alternative for the Proctosedyl suppository supply issue. 

People who want to access Scheriproct suppositories will need a new prescription, because Scheriproct has different active ingredients. 

Schedule listings for anti-haemorrhoidal treatments(external link)

Proctosedyl supply issue

Prescribing and supplying an unapproved medicine

Section 29A of the Medicines Act 1981 allows for medicines that are not Medsafe approved to be prescribed and supplied to people when there is supply issue affecting the registered brand. 

We know supplying an unapproved medicine is not ideal. In this case, however, this will allow people to continue to access an appropriate treatment. 

We apologise for any inconvenience this causes. 

Prescriber and pharmacist requirements for section 29 and 29A medicines – Medsafe website (external link)

What patients need to know about unapproved medicines – Healthify website(external link)

Flier for pharmacists to support conversations with affected people

Resupplied November 2026

Stock has arrived and is available for wholesalers to order from the supplier. It can take another 2 or 3 weeks to reach pharmacies around the country.

Who to contact

If you have questions about this issue, email enquiry@pharmac.govt.nz

Please include as much information as you can about the product (presentation, brand, Pharmacode) and who your wholesaler is.

Sign up to our email list for regular emails about supply issues and more(external link)